Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

STASSI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.746
EU - Europa 9.035
AS - Asia 7.264
SA - Sud America 1.155
AF - Africa 211
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 11
Totale 35.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.528
SG - Singapore 2.663
RU - Federazione Russa 2.211
IT - Italia 2.205
CN - Cina 1.789
BR - Brasile 923
FI - Finlandia 855
DE - Germania 814
HK - Hong Kong 789
UA - Ucraina 675
VN - Vietnam 642
GB - Regno Unito 470
PL - Polonia 436
IE - Irlanda 347
FR - Francia 346
JP - Giappone 257
KR - Corea 185
SE - Svezia 178
IN - India 171
NL - Olanda 146
BD - Bangladesh 118
CA - Canada 103
ID - Indonesia 86
TR - Turchia 86
AR - Argentina 73
BE - Belgio 72
MY - Malesia 69
IQ - Iraq 64
CI - Costa d'Avorio 62
MX - Messico 61
RO - Romania 61
AT - Austria 55
UZ - Uzbekistan 41
EC - Ecuador 37
ES - Italia 36
IR - Iran 34
SA - Arabia Saudita 34
VE - Venezuela 34
ZA - Sudafrica 33
PK - Pakistan 29
KE - Kenya 28
CL - Cile 24
CZ - Repubblica Ceca 24
NP - Nepal 23
CO - Colombia 21
PH - Filippine 21
TH - Thailandia 21
GR - Grecia 19
PY - Paraguay 19
MA - Marocco 18
AU - Australia 17
DZ - Algeria 17
CH - Svizzera 16
JO - Giordania 15
AE - Emirati Arabi Uniti 14
KZ - Kazakistan 14
TN - Tunisia 14
BG - Bulgaria 12
EG - Egitto 12
AZ - Azerbaigian 11
KG - Kirghizistan 11
CR - Costa Rica 10
ET - Etiopia 10
IL - Israele 10
DO - Repubblica Dominicana 9
HN - Honduras 9
OM - Oman 9
UY - Uruguay 9
BH - Bahrain 8
PE - Perù 8
QA - Qatar 8
BO - Bolivia 7
EU - Europa 7
LB - Libano 7
RS - Serbia 7
JM - Giamaica 6
PA - Panama 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
HU - Ungheria 5
KW - Kuwait 5
LT - Lituania 5
NG - Nigeria 5
PS - Palestinian Territory 5
TW - Taiwan 5
AL - Albania 4
HR - Croazia 4
LU - Lussemburgo 4
LV - Lettonia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BY - Bielorussia 3
SV - El Salvador 3
A1 - Anonimo 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
DK - Danimarca 2
Totale 35.408
Salva come PNG Salva come JPEG
Città #
Ashburn 2.141
Fairfield 2.131
Singapore 1.841
Chandler 1.150
Woodbridge 1.107
Houston 889
San Jose 855
Wilmington 789
Cambridge 788
Seattle 776
Ann Arbor 765
Hong Kong 754
Palermo 625
Moscow 401
Zgierz 383
Jacksonville 367
Dublin 344
Council Bluffs 293
New York 283
Medford 262
Beijing 260
Los Angeles 250
Tokyo 243
Santa Clara 228
Helsinki 219
Ho Chi Minh City 219
The Dalles 217
Des Moines 213
Frankfurt am Main 199
Hefei 196
Nanjing 183
Dallas 182
Altamura 175
Princeton 173
Lauterbourg 170
Hanoi 163
Boardman 161
Lawrence 141
San Diego 137
Buffalo 114
Rome 113
Dearborn 109
Milan 99
Tulsa 99
London 95
São Paulo 93
Chicago 88
Ludwigshafen am Rhein 76
Brussels 62
Abidjan 61
Phoenix 59
Orem 58
Seoul 57
Nuremberg 55
Jakarta 54
Munich 54
Nanchang 49
Berlin 47
Changsha 47
Amsterdam 46
Columbus 45
Shenyang 44
Seongnam 43
Falls Church 39
Kuala Selangor 39
Tianjin 39
Warsaw 39
Bremen 37
Hebei 37
Izmir 37
Kumar 36
Stockholm 36
Tashkent 36
Denver 35
Rio de Janeiro 35
Da Nang 33
Brooklyn 32
Guangzhou 32
Jinan 31
Lappeenranta 31
Montreal 31
Paris 31
Shanghai 31
Chennai 30
Haiphong 30
San Paolo di Civitate 29
Poplar 27
Atlanta 26
Jiaxing 26
Redwood City 26
Saint Petersburg 26
Toronto 25
Baghdad 24
City of London 24
Vienna 24
Catania 23
Nairobi 23
Roden 23
Venice 23
Naples 22
Totale 23.468
Salva come PNG Salva come JPEG
Nome #
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis 479
Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients 413
High Levels of Exogenous C2-Ceramide Promote Morphological and Biochemical Evidences of Necrotic Features in Thyroid Follicular Cells 392
Cancer stem cell definitions and terminology: the devil is in the details 372
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition 343
Activated thyroid hormone promotes differentiation and chemotherapeutic sensitization of colorectal cancer stem cells by regulating Wnt and BMP4 signaling 325
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 324
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 304
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance 301
Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown 300
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 298
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 298
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage 297
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 297
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells 293
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 293
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells. 283
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 283
Tumor and its microenvironment: a synergistic interplay. 276
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 275
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities 274
Colorectal cancer defeating? Challenge accepted! 267
MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells 265
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 259
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 257
Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. 256
Survivin is regulated by interleukin-4 in colon cancer stem cells 255
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models 254
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer 248
CANCER STEM CELLS CONTRIBUTE TO THE AGGRESSIVE BEHAVIOUR OF HUMAN EPITHELIAL COLON CANCER. 245
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy 244
PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells 241
Normal vs cancer thyroid stem cells: the road to transformation 240
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 240
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 239
Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanism. 239
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis 239
Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy 237
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study. 236
Immunotherapy targeting colon cancer stem cells 234
Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy 234
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. 233
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes 233
Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. 232
Colorectal Cancer Stem Cells: From the Crypt to the Clinic 228
Innovative Therapeutic Strategies Targeting Colorectal Cancer Stem Cells 227
Meeting the Challenge of Targeting Cancer Stem Cells 226
Isolation and culture of colon cancer stem cells. 225
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 225
Cancer cell targeting by CAR-T cells: A matter of stemness 224
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment 224
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 222
Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells 222
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells 220
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 218
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 217
Lipid droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging 216
Autocrine production of IL-4 confers resistance to chemotherapy and CD-95 induced cell death in cancer cells. 215
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs 215
Differentiation, phenotype, and function of interleukin-17-producing human V{gamma}9V{delta}2 T cells 214
Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells 212
Therapeutic implications of Cancer Initiating Cells. 211
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 211
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 210
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. 209
C1Q+ TPP1+ macrophages promote colon cancer progression through SETD8-driven p53 methylation 207
Mechanisms underlying lineage commitment and plasticity of human γδ T cells. 207
Estrogens and stem cells in thyroid cancer 205
γδ T cells as a potential tool in colon cancer immunotherapy 204
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy 204
V{gamma}9V{delta}2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells. 203
Tumorigenic and metastatic activity of human thyroid cancer stem cells 203
A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening 202
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype 201
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 201
Colon cancer stem cells: promise of targeted therapy. 200
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells 197
IL-4-mediated drug resistance in colon cancer stem cells 195
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 195
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells 195
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme 194
Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules 194
Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 193
ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREAMENT OF CANCER 192
Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs 192
Apoptosis induced by a HIPK2 full-length-specific siRNA is due to off-target effects rather than prevalence of HIPK2-Δe8 isoform. 191
CD133 as a target for colon cancer. 189
Identification and phenotypic characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells 185
Cancer-Initiating Cells from Colorectal cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 185
Colorectal cancer stem cells and cell death 182
IL-21 regulates the differentiation of a human γδ T cell subset equipped with B cell helper activity. 179
Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease 179
ROLE OF IL-4 AND IL-10 CYTOKYNES IN THE PATHOGENIC MECHANISM OF THYROID CANCER. 178
Role of interleukin-4 on colon cancer stem cell survival 177
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer 177
Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patients 176
Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids 176
Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor–Related Apoptosis-Inducing igand–Mediated Destruction. 175
A versatile ultrasound system for in vitro experiments 175
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity 173
Totale 23.619
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021553 0 0 0 0 0 0 0 0 0 0 290 263
2021/20222.621 145 503 100 82 151 97 143 140 301 319 187 453
2022/20233.272 310 584 59 404 343 564 184 225 370 39 129 61
2023/20241.506 88 211 93 91 116 301 161 98 17 48 18 264
2024/20254.035 110 257 196 339 141 140 300 316 283 525 526 902
2025/202613.346 1.071 376 851 1.080 1.295 2.050 1.940 1.308 1.099 1.801 475 0
Totale 36.518